Zacks Investment Research·Sep 4, 2026
Are Robots the New Normal? Bet on these ETFs to Invest in the FutureRobotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.
Novanta is executing a strategic deleveraging and balance sheet fortification, with total debt down to $282.8M and cash surging to $718.6M by 2026Q2, while revenue growth accelerates to 10.3% YoY. However, earnings quality is clouded by stock-based compensatio...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth accelerated to 10.3% YoY in 2026Q2 reaching $265.8M, yet operating margin fell to 6.8% as SG&A surged 27.4% YoY and SBC spiked to $19.6M, indicating margin pressure despite gross margin expansion to 45.5%.
Novanta reported Q1 2026 earnings and revenue beats, marking two consecutive quarters of exceeding estimates.
The company partners with leading OEMs in medical and advanced manufacturing to solve mission-critical challenges.
Novanta's culture of collaboration and bold innovation enables solving customers' toughest problems across continents.
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $0.89+7.2% vs $0.83 | $266M+1.3% vs $262M |
Q2 2026 May 11, 2026 | $0.81+3.8% vs $0.78 | $258M+1.7% vs $253M |
Q1 2026 Feb 23, 2026 | $0.91+3.4% vs $0.88 | $258M+1.1% vs $256M |
Q4 2025 Nov 3, 2025 | $0.87+7.4% vs $0.81 | $248M-3.0% vs $256M |
Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.
Connor Clark and Lunn Investment Management Ltd. acquired a new position in Novanta Inc. (NASDAQ: NOVT) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,845 shares of the technology company's stock, valued at approximately $786,000. Several other large investors have
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical a.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Benchmark NOVT against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Novanta Inc. (NOVT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $134.31 | $4.78B | 91.37 | 3.3% | 5.49% | 5.23% | — | |
| $256.92 | $17.35B | 58.79 | 9.62% | 10.12% | 15.83% | — | |
| $61.99 | $10.32B | 91.16 | 8.73% | 16.05% | 11.48% | — | |
| $321.52 | $62.9B | 270.18 | -64.79% | 11.31% | 8.09% | — | |
| $84.08 | $4.4B | 9999.00 | -7.38% | 12.18% | 13.55% | — | |
| $77.75 | $3.3B | 106.51 | 2.73% | 2.58% | 1.3% | — |
Novanta Inc. (NOVT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Novanta Inc. (NOVT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jul 27, 2026·SEC
Jun 9, 2026·SEC
Get notified when NOVT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Novanta Inc. (NOVT) stock FAQ — growth, dividends, profitability & financials explained
Novanta Inc. (NOVT) reported $1.03B in revenue for fiscal year 2025. This represents a 614% increase from $144.2M in 1998.
Novanta Inc. (NOVT) grew revenue by 3.3% over the past year. Growth has been modest.
Yes, Novanta Inc. (NOVT) is profitable, generating $61.8M in net income for fiscal year 2025 (5.5% net margin).
Novanta Inc. (NOVT) has a return on equity (ROE) of 5.2%. This is below average, suggesting room for improvement.
Novanta Inc. (NOVT) generated $160.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
